AMRI: Albany Molecular Research Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMRI: Albany Molecular Research

AMRI 21.74

0.0%

Sep 1 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

PreviousNext

From: pcyhuang	9/26/2001 4:47:42 AM
	of 1

AMRI, leader in drug discovery and development We are adding Albany Molecular Research (AMRI @$20.10) to our recommended list. AMRI is a drug discovery and development company focused on applications for the pharmaceutical, biotechnology and life sciences industries. For the six months ended 6/30/01, revenues rose 51% to $45.4 million. Net income rose 62% to $16.7 million. AMRI has had four consecutive quarters of positive earnings surprises. We estimate the AMRI will earn $1.00 per share this year on revenue of $95 million, and $1.20 per share next year. <a href="http://moneycentral.msn.com/investor/research/profile.asp?Symbol=amri">Click here for detailed company report. </a> pcyhuang huangcapital.com Huang's Mechanical Hedge Investing

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

PreviousNext